FORTIS vs MEDANTA: Stock Comparison

FORTIS HEALTHCARE vs GLOBAL HEALTHUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

FORTIS HEALTHCARE is the larger company by market capitalisation. FORTIS HEALTHCARE shows a lower P/E and a higher dividend yield, while GLOBAL HEALTH shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

FORTIS leads 6; MEDANTA leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

FORTISMEDANTA

Valuation lens

What price are you paying?

Market CapContext only
₹66,987 Cr
₹38,774 Cr
P/E RatioFORTIS has the lower reading
63.93x
69.7x
P/B RatioFORTIS has the lower reading
6.77x
9.78x
EPSMEDANTA has the higher reading
₹3.53
₹5.9
Book ValueContext only
₹134.69
₹148.18
Dividend YieldFORTIS has the higher reading
0.11%
0.03%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
FORTIS is the larger company
₹66,987 Cr vs ₹38,774 Cr
P/E Ratio
FORTIS has a lower P/E
63.93x vs 69.7x
P/B Ratio
FORTIS has a lower P/B
6.77x vs 9.78x
EPS
MEDANTA has higher earnings per share
₹5.9 vs ₹3.53
Dividend Yield
FORTIS has a higher dividend yield
0.11% vs 0.03%
Revenue Growth (TTM YoY)
MEDANTA has faster revenue growth
24.5% vs 17.8%
EPS Growth (TTM YoY)
FORTIS has faster EPS growth
44.3% vs 42%
Qtr Sales Growth
FORTIS has stronger quarterly sales growth
419.98% vs 20.89%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFORTISMEDANTA
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricFORTISMEDANTA
Live Price₹887.8₹1,447.2
Day Change-1.62%-0.85%
Volume7.85 L74,678
52-Week High₹1,104.3₹1,544
52-Week Low₹766.8₹956
Distance from 52W High-19.61%-6.27%

Valuation

MetricFORTISMEDANTA
Market Cap₹66,987 Cr₹38,774 Cr
P/E Ratio63.93x69.7x
P/B Ratio6.77x9.78x
EPS₹3.53₹5.9
Book Value₹134.69₹148.18
Dividend Yield0.11%0.03%

Growth

MetricFORTISMEDANTA
Revenue Growth (TTM YoY)17.8%24.5%
EPS Growth (TTM YoY)44.3%42%
Qtr Sales Growth419.98%20.89%
Qtr Profit Growth470.95%14.53%

Profitability & Leverage

MetricFORTISMEDANTA
ROE10.47%12.37%
ROCE10.23%11.4%
Net Margin11.41%12.62%
Operating Margin18.23%18.62%
Debt to Equity0.28x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFORTISMEDANTA
Promoter Holding0%33% 0.01 pp
FII Holding25.2% 0.77 pp9.46% 0.69 pp
DII Holding32.23% 0.88 pp16.89% 2.13 pp
Public Holding11.4% 0.11 pp40.56% 1.44 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FORTIS HEALTHCARE and GLOBAL HEALTH.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.